Inactive Instrument

Highlights CROSSJECT Euronext Paris

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

04:44pm	CROSSJECT : We are still believers	AL
10/07	Markets Powered by Alternating Current

CROSSJECT : We are still believers	08:14pm	AL
Crossject Gets EUR7 Million Public Funding for New Epinephrine Product	10/07	MT
Crossject: public financing secured until 2026	10/07	CF
Crossject: successful capital increase	05/06	CF
CROSSJECT : Success of the capital increase	05/06	AL
Crossject Raises EUR8 Million via Rights Offering	05/06	MT
Crossject: capital increase until May 30	27/05	CF
Crossject: praised for extended agreement on Zepizure	03/05	CF
Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	02/05	CI
CROSSJECT : Patience is a virtue… hopefully	03/04	AL
Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
CROSSJECT : Invest Securities slightly reduces its target	28/02	CF
CROSSJECT : Securing the financing needs	28/02	AL
Crossject: share price falls after convertible bond issue	27/02	CF
CROSSJECT : No news is not always good news...	08/02	AL
Crossject: strategy advances, but visibility worries	07/02	CF
CROSSJECT : Marketing initiative in the US	06/01	AL
French Pharmaceutical Crossject Taps Syneos Health for US Commercialization of Epilepsy Rescue Treatment	05/01	MT
CROSSJECT : A new distribution agreement in Northern Europe	03/01	AL
Crossject: commercial agreement in Northern Europe	22/12	CF

No results for this search